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Long-term potentiation (LTP) is the key cellular mechanism for physiological learning and pathological chronic pain.
In the anterior cingulate cortex (ACC), postsynaptic recruitment or modification of AMPA receptor (AMPAR) GluA1
contribute to the expression of LTP. Here we report that pyramidal cells in the deep layers of the ACC send direct
descending projecting terminals to the dorsal horn of the spinal cord (lamina I-III). After peripheral nerve injury,
these projection cells are activated, and postsynaptic excitatory responses of these descending projecting neurons
were significantly enhanced. Newly recruited AMPARs contribute to the potentiated synaptic transmission of cingulate
neurons. PKA-dependent phosphorylation of GluA1 is important, since enhanced synaptic transmission was abolished
in GluA1 phosphorylation site serine-845 mutant mice. Our findings provide strong evidence that peripheral nerve
injury induce long-term enhancement of cortical-spinal projecting cells in the ACC. Direct top-down projection system
provides rapid and profound modulation of spinal sensory transmission, including painful information. Inhibiting
cortical top-down descending facilitation may serve as a novel target for treating neuropathic pain.Introduction
Chronic pain is a major health problem that causes eco-
nomic loss world-wide. The lack of effective drugs to con-
trol chronic pain, especially neuropathic pain, is in part
due to our poor understanding of the basic neurobiology
of pain at the molecular and cellular levels [1-4]. For
example, what changes occur in the brain in response to
peripheral insults? Are these changes long-lasting? If so,
do these changes affect subsequent sensory processes after
injury? Long term plasticity in synaptic transmission is be-
lieved to be the key cellular mechanism for not only learn-
ing and memory, but also for storing sensory information
in the brain [5-8]. In the case of chronic pain, peripheral
injury triggers long term potentiation (LTP) in the spinal
dorsal horn and cortical synapses, suggesting that LTP
serves as the cellular model for chronic pain [3,4,9-12].* Correspondence: deptanat@fmmu.edu.cn; minzhuo10@gmail.com
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unless otherwise stated.The anterior cingulate cortex (ACC) is believed to be im-
portant for mediating emotional and attentive responses to
internal and external noxious stimuli [3,4,13-16]. Various
electrophysiological experiments have demonstrated that
ACC neurons respond to noxious stimuli in different spe-
cies including mouse, rat, rabbit, monkey and human
[17-20]. More recently, works based on animal models of
chronic pain have begun to reveal the cellular and molecu-
lar mechanisms of pain-induced LTP in the ACC (see [4]
for review). It has been found that excitatory synaptic
transmission in the layer II/III neurons of ACC could be
enhanced by peripheral inflammation, nerve injury or digit
amputation [21-23]. Furthermore, theta-burst stimulation
(TBS) induced late-phase LTP in the ACC was occluded in
animals with nerve injury [21]. In accordance with synaptic
studies, inhibiting or erasing LTP in the ACC can reduce
behavioral hyperalgesia [21,24,25], suggesting that they
share similar neuronal mechanisms [4].
It is well known that spinal nociceptive transmission re-
ceives descending inhibitory and facilitatory modulation
from supraspinal structures such as the midbrain peria-
queductal grey (PAG) and rostral medical medulla (RVM)td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tion of the ACC facilitated spinal tail-flick reflex by acting
through brainstem descending modulation system [32],
few works on the possible direct top-down corticospinal
modulation in pain have been reported. Previous anatomic
studies report that some prefrontal cortical areas, includ-
ing part of the dorsal ACC, send descending projections
to the spinal cord in rats and monkeys [33,34]. This link
provides possible pathway for ACC neurons to directly
regulate the spinal cord neurons. In the present study, we
employ integrative experimental approaches to show that
long-term plastic changes taking place in these spinal cord
projecting neurons in the deep layers of the ACC after
nerve injury. The potentiated corticospinal projection will
play direct and potent effects in pain regulation.
Results
Corticospinal projections from the ACC in adult mice
Since the dorsal horn of spinal cord (SC) is important
for the transmission of nociceptive information, we
firstly tested whether there were direct projections from
the ACC to the spinal dorsal horn in adult mice. To
investigate this, we injected the retrograde tracer Fluoro-
Gold (FG) into the dorsal horn of mouse SC (n = 6 mice)
(Figure 1A). Seven days after injection, FG-retrogradely
labeled cortical neurons were observed in the bilateral
sides of the ACC from 0.3-1.1 mm anterior to the
bregma, with the contralateral predominance (71.3 ±
3.3% of FG labeled cells) (Figure 1B). Most of the FG
retrograde labeled neurons were located in layer V, with
scattered FG labeled neurons found in layer VI. Few or
no labeled cells were found in the superficial layers
(layers I-III) (Figure 1E-F). Furthermore, more FG-
labeled neurons were found in the dorsal ACC (Table 1).
Injection of FG may label passing nerve fibers near the
injection area. We thus explored anterograde labeling
methods to further confirm the direct projections from
the ACC to the spinal dorsal horn. We firstly injected
phaseolus vulgaris leucoagglutinin (Pha-L), a widely used
anterograde neuronal tracer [35,36], into the ACC. Two
weeks later, the Pha-L anterograde labeled fibers and
terminals were detected in the dorsal layers of the spinal
cord, in which most of the varicose and punctate fibers
and terminals were distributed in laminae I and II and
scattered fibers and terminals were observed in lamina
III. No obvious fibers and terminals could be observed
in deeper layers (Figure 2). Traditional anterograde
tracers, including the Pha-L may have diffusion capacity
in injected sites [37], we next used a modified antero-
grade tracing strategy based on lentivirus-assistant rabies
virus system to only stain a small region of the deep ACC
and check their projections to the spinal cord. The vesicu-
lar stomatitis virus glycoprotein (VSV-G) pseudotyped
Lenti-TVA-mKate infected the neurons anterogradely,which located in the ACC and expressed the avian recep-
tor protein (TVA) and mKate restrictlly in the infected
neurons (Figure 3) [38]. The rabies virus EnvA-RV-
mcherry was a glycoprotein deleted virus and was pseudo-
typed with the avian sarcoma leucosis virus glycoprotein
(EnvA) [39,40]. The EnvA-RV-mcherry could only infect
the neurons that express TVA and labeled these Lenti-
TVA-mKate infected ACC neurons locally (Figure 3A).
We found that one week after the rabies infection in
limited group of neurons in the deep layers of ACC
(Figure 3B), virus infected varicose fibers and terminals
(immunostained with FITC) were detected in the superfi-
cial layers (laminae I-III) of the spinal cord. Although the
number of virus infected fibers and terminals was signifi-
cantly less than that of Pha-L labeled ones, their distribu-
tion patterns were similar (Figures 2 and 3).
Peripheral nerve injury increased Fos expression in spinal
cord but not ventral striatum projecting neurons in the
layer V of the ACC
Confirmation of the projections from the ACC to the SC
leads us to wonder if they are related to pain regulation.
We then tested the expression of Fos protein, a widely
used activity marker [41], in mice exposed to common
peroneal nerve (CPN) ligation surgery – a model of
neuropathic pain [21]. As expected, significantly more ex-
pression of Fos protein was observed in layer V neurons
of the ACC in mice with nerve injury as compared with
mice receiving sham surgery (Table 1). Among ACC- SC
projecting neurons, many of them expressed Fos after
nerve injury (mean 71.3 ± 7.3%) (n = 3 mice) (Figure 1C-D)
(Table 1). In comparison, we tested the Fos expression
in the ACC-ventral striatum (VS) projecting neurons
(Figure 4A), which are more likely to be involved in reward
function [42]. After FG injection into the VS, FG labeled
neurons were observed in the bilateral ACC (Figure 4B).
Unlike the corticospinal projecting cells, most of the ACC-
VS projecting neurons were found in the ipsilateral ACC
(Table 2). FG labeled neurons were distributed mainly in
layer V of the dorsal part of the ACC, with scattered neu-
rons in the layers III and VI, but no detectable FG labeled
cells in layers I and II. Moreover, Fos staining revealed only
small percentage of ACC-VS projection cells were acti-
vated after nerve injury (Table 2; Figure 4C-D).
Potentiated AMPA receptor (AMPAR)-mediated
postsynaptic responses
Previous studies in the ACC found that excitatory trans-
mission in layer II-III pyramidal cells are potentiation after
peripheral nerve injury or inflammation (see [3,4] for
reviews). Little information is available about excitatory
synaptic transmission in deep cingulate neurons. There-
fore, we decided to record the AMPAR mediated excita-
tory postsynaptic currents (EPSCs) on layer V pyramidal
Figure 1 Fos/FG double labeling after Fluoro-Gold injection into the spinal cord. A, Schematic figures and digitized photomicrograph showing
Fluoro-Gold (FG) injection site in the spinal cord and retrograde transportation of FG label neurons in the ACC. B, Distribution of FG labeled neurons in
both sides of ACC after FG injection into the spinal cord. C, D, Augmented figures showing FG (green) and Fos (red) double-labeling results in
rectangle area 1 (C) and 2 (D) in B. Arrowheads on the merged figures indicate FG/Fos double-labeled neurons. E, After FG injection into one side of
the dorsal part of spinal cord, the FG retrogradely labeled cells in the ACC was immunostained with anti-FG antibody and shown with ABC method.
With Nissl counterstaining, most of the FG labeled cells are shown to be located within the layer V of the ACC. F, Augmented figures from upper (left)
and lower (right) rectangled areas in E showed FG labeled neurons located in the layer V of the ACC. Bars equal to 200 μm in A, B and E and 20 μm in
C, D and F.
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Table 1 Numbers of Fos-immunoreactive (ir), FG-labeled and Fos/FG dual-labeled neurons (dorsal/ventral) in the
contralateral anterior cingulate cortex after FG injection into the spinal cord













M1 933/416 178/21 121/2 (9.1; 61.8) M4 103/33 221/15 19/2 (15.4; 8.9)
M2 781/326 226/52 200/29 (20.7; 82.4) M5 112/31 146/9 17/0 (11.9; 11.0)
M3 1152/368 155/20 109/13 (8.0; 69.7) M6 121/42 155/10 24/7 (19.0; 18.8)
The two sets of data in each bracket indicates the number of neurons located in the dorsal or the ventral part of the ACC, respectively.
%1: the percentage of total Fos/FG dual-labeled neurons (the sum of dorsal and ventral part of the ACC) to total Fos-ir neurons. %2: the percentage of total Fos/
FG dual-labeled neurons to total FG-labeled neurons.
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responses are also enhanced after nerve injury (Figure 5A).
We found that the input (stimulation intensity)–output
(EPSC amplitude) curve (I-O curve) of AMPAR responses
had steeper slope after peripheral nerve injury, compared
with that of neurons from the sham surgery group (n = 12
neurons/9 mice in each group, two way ANOVA followed
with Tukey’s post hoc test, F (1, 110) = 42.147, p < 0.001)
(Figure 5B), indicating that excitatory responses are poten-
tiated after nerve injury. The AMPAR mediated EPSCs
at the different holding potentials (−60 to +50 mV)
were also recorded, and we found an obvious inward
rectification of the mean I-V curve in mice with nerveFigure 2 Distribution of Pha-L anterograde labeled fibers and termina
sample figure from a sagittal slice (A) showing that Pha-L labeled fibers an
after Pha-L injection into one side of the ACC (B). The rectangled areas (1–
A, 200 μm in B, 10 μm in C-G.injury (sham surgery: n = 7 neurons/6 mice, nerve
injury: n = 9 neurons/7 mice; p < 0.05) (Figure 5C).
To determine if presynaptic transmitter release is altered
in response to nerve injury, we measured the frequency of
the miniature EPSCs (mEPSC) and the ratio of paired-pulse
facilitation (PPF), two simple measurements for presynaptic
transmitter release possibility. After nerve injury, no change
in the frequency of the mEPSCs (n = 18 neurons/9 mice in
each group, p > 0.05) and PPF ratios (n = 18 neurons/9 mice
in each group, two way ANOVA, F (1, 170) = 0.161, p > 0.05)
were detected (Figure 5D-E). These results suggest that pre-
synaptic release of glutamate is unlikely enhanced on layer
V pyramidal cells by nerve injury.ls in the spinal dorsal horn projected from the ACC. A-B, One
d terminals were distributed in the laminae I-III of the spinal cord (c4)
5) in A were augmented in C-G respectively. Bars equal to 100 μm in
Figure 3 Distribution of rabies virus anterograde labeled fibers and terminals in the spinal dorsal horn projected from the ACC. A, The
schematic figure showing the design of lentivirus-assistant rabies virus used for anterograde tracing. B-D, After the virus injection into one side of
the ACC (B), virus infected fibers and terminals were distributed in the laminae I-III of the spinal cord (c4) (C-D). Rectangled areas of 1–5 in C and
D were augmented in E-I respectively. Bars equal to 200 μm in B, 50 μm in C and D, 10 μm in E-I.
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jecting neurons in the ACC are more likely to be acti-
vated after nerve injury. It is important to determine if
AMPAR mediated EPSCs are selectively enhanced in
ACC-SC projecting neurons. After retrograde labeling
ACC projecting cells by DiI (0.25%) or Alexa-488 con-
jugated Dextran (10%) (Figure 6A), we performed elec-
trophysiological recordings from retrogradely labeled
cells that were randomly selected from both sides of
the ACC. We found that the I-O curve of AMPAR me-
diated EPSCs of spinal cord projecting neurons has
steeper slope in mice with nerve injury, as compared
with SC projecting neurons of mice with sham surgery
(sham surgery: n = 6 neurons/5 mice. nerve injury: n =
12 neurons/9 mice; Two-way ANOVA followed with
Tukey’s post hoc test, F (1, 80) = 22.461, p < 0.001). Inter-
estingly, nerve injury did not affect the I-O curve in
ACC-VS projecting neurons (sham surgery: n = 6 neu-
rons/5 mice. nerve injury: n = 8 neurons/6 mice; Two
way ANOVA, F (1, 60) =1.531, p > 0.05) (Figure 6B).Calcium-permeable AMPAR (CP-AMPAR) contributes to
the potentiation
AMPAR is heterotetramer of four homologous subunits
(GluA1 to GluA4) that combine in different stoichiome-
tries to form different subunits [43]. In normal conditions,
most of the AMPAR contain the GluA2 subunit. During
synaptic plastic changes, GluA2 can be replaced by
GluA1/3 subunit [44,45], which is Ca2+ permeable
AMPAR (CP-AMPAR) and inwardly rectifying [46]. Ac-
cording to the observed inward rectification of the mean
I-V curve in mice with nerve injury (Figure 5C), we expect
that the potentiated AMPAR mediated responses in the
ACC layer V may be sensitive to the inhibition of CP-
AMPAR antagonist NASPM. We next recorded AMPAR
mediated responses from ACC neurons in mice with
nerve injury and found that NASPM inhibited the I-O
responses (F (1, 80) = 29.163, p < 0.001, n = 9 neurons/6
mice, two way ANOVA followed with Tukey’s post hoc
test). Meanwhile, NASPM didn’t inhibit the I-O responses
in mice with sham surgery (F (1, 80) =0.849, p > 0.05, n = 9
Figure 4 Fos/FG double labeling after Fluoro-Gold injection into the ventral striatum. A, Schematic figures and digitized photomicrograph
showing FG injection site in the ventral striatum and retrograde transportation of FG to label neurons in the ACC. B, Distribution of FG labeled
neurons in both sides of ACC with FG injection into the ventral striatum. C-D, Augmented figures showing FG (green) and Fos (red) double-
labeling results in rectangle area 1 (C) and 2 (D) in B. Arrowheads on the merged figures indicate FG/Fos double-labeled neurons. Bars equal to
1000 μm in A, 200 μm in B, and 20 μm in C and D.
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more, the AMPAR mediated eEPSCs were significantly
inhibited by bath application of NASPM (50 μM) (75.3 ±
6.0% of baseline; n = 8 neurons/7 mice, paired t-test, p <
0.05). The same application of NASPM did not affect
AMPAR mediated responses in ACC neurons recorded
from mice with sham surgery (95.0 ± 5.2% of baseline;
n = 7 neurons/6 mice, p > 0.05) (Figure 7A).
ACC-SC but not ACC-VS projecting neurons showed
increased Fos expression, as well as potentiated AMPAR
mediated responses. We therefore further investigated the
effect of NASPM on these projecting neurons. After bathTable 2 Numbers of Fos-immunoreactive (ir), FG-labeled and








M1 845/310 116/12 9/2 (1.0; 8.6)
M2 779/298 101/16 12/3 (1.4; 12.8)
M3 959/294 116/11 15/5 (1.6; 15.7)
The two sets of data in each bracket indicates the number of neurons located in th
%1: the percentage of total Fos/FG dual-labeled neurons (the sum of dorsal and ve
Fos/FG dual-labeled neurons to total FG-labeled neurons.application of NASPM, the enhanced I-O responses on
ACC-SC projecting neurons in mice with nerve injury
(F (1, 70) =24.576, p < 0.001, n = 8 neurons/5 mice, two
way ANOVA followed with Tukey’s post hoc test) were
inhibited. This inhibition was not observed on ACC-SC
projecting neurons in mice with sham surgery (two way
ANOVA, F (1, 60) =0.052, p > 0.05, n = 7 neurons/5 mice)
or on ACC-VS neurons in mice with either sham surgery
(F (1, 60) =0.402, p > 0.05, n = 7 neurons/6 mice, two way
ANOVA) or nerve injury (F (1, 60) =1.320, p > 0.05, n = 7
neurons/5 mice, two way ANOVA) (Figure 6D, E). In con-









M4 85/24 120/11 10/1 (10.1; 8.4)
M5 106/68 132/15 15/3 (10.3; 12.2)
M6 96/35 106/10 11/4 (11.5; 12.9)
e dorsal or the ventral part of the ACC, respectively.
ntral part of the ACC) to total Fos-ir neurons. %2: the percentage of total
Figure 5 Nerve injury increased the AMPAR mediated postsynaptic responses in the ACC. A, Schematic figures showing the recording on
layer V by stimulating shallow layers (II/III), plus one biocytin labeled layer V pyramidal cell. B, The input–output curve of ACC layer V neurons
became steeper in mice with nerve injury, compared with mice with sham injury. Two-way ANOVA followed by Tukey’s post hoc test; C, An
inward rectification of AMPA I-V curve of layer V neurons after nerve injury. D-E, The frequency of the mEPSC (D) and the paired-pulse ratio (E) is
not changed after nerve injury.
Figure 6 GluA1/3 mediated the potentiated input–output responses in ACC-spinal cord projecting neurons. A, Digitized photomicrograph
showing one DiI retrogradely labeled neuron after injection into the spinal cord (SC) was whole-cell patched and dual labeled by intracellular injection
of Alex-488 (1), and one Alex-488 Dextran retrogradely labeled neuron after injection into the ventral striatum (VS) was patched and dual labeled with
Alex-594(2). B, Samples and summarized results showing the I-O curve in ACC-SC projecting neurons in mice with nerve injury has steeper slope, as
compared with ACC-SC projecting neurons in mice with sham surgery. Meanwhile, the I-O curve in ACC-VS projecting neurons was not different in mice
with or without nerve injury. C, Bath application of NASPM only inhibited the I-O responses of neurons from nerve injury but not sham surgery group.
D, Bath application of NASPM only inhibited the I-O responses of ACC-SC projecting neurons from nerve injury but not sham surgery group. E, Bath
application of NASPM inhibited the I-O responses of ACC-VS projecting neurons from neither nerve injury nor sham surgery group. F. Nerve injury
enhanced the I-O responses of ACC-SC projecting neurons in s831A mice but not in s845A mice. Bar equals to 20 μM in A. *,p < 0.05; ***,p < 0.001.
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Figure 7 GluA1/3 mediated the potentiation of the AMPAR mediated basal synaptic transmission in ACC-spinal cord projecting neurons.
A, Samples and the averaged results showing that NASPM inhibited the AMPAR EPSCs in mice with nerve injury but not in mice with sham surgery.
B, Samples and averaged results showing that NASPM only inhibited the AMPAR EPSCs in ACC-SC projecting neurons in mice with nerve injury but
not in mice with sham surgery. C, NASPM did not inhibit the AMPAR EPSCs in ACC-VS projecting neurons in mice either with or without nerve injury.
D, Plotted figure shows the summarized effect of NASPM on unlabeled or retrograded labeled projecting neurons. E-G, NASPM can only inhibit the
AMPAR EPSCs of ACC-SC projecting neurons in s831A mice with nerve injury, but not in s845A mice with nerve injury, as well as s831A and s845A mice
with sham surgery. *,p < 0.05; **,p < 0.01; ***,p < 0.001.
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with nerve injury (65.7 ± 7.7% of baseline; n = 8 neurons/
7 mice, paired t-test, p < 0.01) but not in mice with sham
treatment (101.9 ± 7.8% of baseline; n = 6 neurons/5 mice,
paired t-test, p > 0.05) (Figure 7B, D). Furthermore,
AMPAR mediated eEPSCs from ACC-VS projecting neu-
rons were not affected by bath application of NASPM
(sham surgery: 103.6 ± 11.4% of baseline, n = 6 neurons/5
mice; nerve injury, 98.4 ± 1.9% of baseline, n = 7 neurons/
5 mice. paired t-test, p > 0.05) (Figure 7C-D).
GluA1 PKA phosphorylation site is important for nerve
injury induced synaptic potentiation
Phosphorylation of GluA1 is important for GluA1 traf-
ficking and synaptic plasticity [47,48]. Previous studies
showed that nerve injury increased GluA1 PKA phos-
phorylation at the serine 845 site in the ACC, by using
western blot method [22]. However, it is unknown if
PKA phosphorylation of GluA1 is required for nerve
injury induced synaptic potentiation of ACC neurons.
Taking advantage of genetically induced GluA1 phos-
phorylation site knock in mice [45], we performed
electrophysiological recordings from ACC-SC project-
ing neurons to test if these mutations affected injury
induced synaptic potentiation. We found that enhanced
AMPAR I-O responses after the injury was completely
abolished in PKA phosphorylation s845A mutant mice
(sham surgery: n = 7 neurons/6 mice; nerve injury: n = 7neurons/5 mice, Two way ANOVA, F(1, 60) = 0.028, p >
0.05), but not in PKC phosphorylation s831A mice
(sham surgery: n = 7 neurons/6 mice; nerve injury: n = 8
neurons/7 mice, Two way ANOVA followed with Tukey’s
post hoc test, F (1, 65) =22.339, p < 0.001) (Figure 6F). Base-
line AMPAR responses were not different in these two
lines of mice. We further examined the effect of NASPM
on the ACC-SC projecting neurons in s845A and s831A
mice. We found that bath application of NASPM signifi-
cantly inhibited AMPAR eEPSCs in PKC phosphorylation
s831A mice (65.8 ± 2.0% of baseline; n = 7 neurons/6 mice,
paired t-test, p < 0.001) but not in PKA phosphorylation
s845A mice (97.6 ± 3.6% of baseline; n = 6 neurons/6 mice,
paired t-test, p > 0.05) with nerve injury (Figure 7E-G).
These results strongly suggest that CP-AMPAR accumula-
tion in the synaptic region is prevented by the GluA1
mutation on the PKA phosphorylation site, but not on
the PKC phosphorylation site.
Excitatory unitary transmission from ACC layer III to layer V
It has been proposed that ACC superficial layer (II/III)
cells send their projections to deeper layer V/VI cells
[49,50]. To determine if inter-layer excitatory synapses
may undergo potentiation after injury, we performed dual
patch recordings in ACC neurons of mice aged 6–7
weeks. In a total of 14 mice (88 dual recording experi-
ments), three pairs of neurons between presynaptic layer
III and postsynaptic layer V connections were obtained
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Action potentials (APs) were induced in presynaptic (layer
III) neurons by a brief (1 ms) depolarizing voltage pulse
(from −60 mV to +20 mV) at 0.05 Hz and postsynaptic
unitary AMPAR EPSCs were thus recorded [51]. We
found that presynaptic AP-evoked postsynaptic EPSCs
were inhibited by bath applications of NASPM (50 μM) in
ACCs from mice with nerve injury (58.3 ± 10.8% of base-
line, paired t-test, p < 0.05) but not from mice with sham
surgery (93.4 ± 5.6% of baseline, paired t-test, p > 0.05)
(Figure 8). These findings suggest that injury induced
plastic changes take place in local excitatory synapses,
especially those linking layer III to layer V ACC neurons.
Electrophysiological recordings from injury activated
Fos-positive ACC layer V neurons
To test whether AMPAR mediated currents are enhanced
in injury triggered Fos-positive layer V neurons, we used
transgenic mice in which the expression of GFP is con-
trolled by the promoter of the c-fos gene [52,53]. After
peripheral injury, the c-fos gene was activated and neurons
can therefore be detected with GFP expression in trans-
genic mice [21]. Seven days after nerve injury, strong
FosGFP-positive neurons were found in layer V of the
ACC in Fos-GFP mice (Figure 9A). We then performed
whole-cell patch recording from FosGFP-positive (Fos+)
neurons. Recordings from FosGFP-negative (Fos-) neu-
rons were also performed in the same slices for the com-
parison. We found that the I-O curves of AMPAR EPSCsFigure 8 Nerve injury enhanced the layer III-layer V unitary AMPAR re
III-layer V unitary AMPAR responses in mice with nerve injury but not in mi
NASPM on the layer III-layer V unitary AMPAR responses in mice with nerve
the AMPA current. E, Fluorescent figure showing one pair of neurons label
(red, layer III). *,p < 0.05.significantly shifted to the left in Fos + neurons of mice
with nerve injury, compared with those from Fos- neurons
in mice with nerve injury or Fos- neurons in sham-
operated mice (sham surgery: n = 9 Fos- neurons/6 mice,
nerve injury: n = 9 Fos- neurons/6 mice and 10 Fos + neu-
rons/7 mice, Two way ANOVA, F(2, 139) = 25.293, p <
0.001) (Figure 9B). We then applied NASPM to Fos+ or
Fos- neurons in mice with nerve injury or Fos- neurons in
mice with sham surgery. In mice with nerve injury, the
AMPAR mediated eEPSCs of Fos + neurons were inhibited
significantly (n = 7 neurons/7 mice, 55.1 ± 7.6% of baseline;
paired t-test, p < 0.05) but not in Fos- neurons (n = 6 neu-
rons/6 mice, 97.0 ± 11.8% of baseline; p > 0.05). Moreover,
AMPAR mediated responses on Fos- neurons from sham
surgery mice were not affected either (n = 5 neurons/5
mice, 96.3 ± 8.3% of baseline; p > 0.05) (Figure 9C-D).
Discussion
In the present study, we have demonstrated that postsyn-
aptic recruitment of GluA1 mediated the nerve injury in-
duced LTP, especially on the corticospinal projecting
neurons of the ACC in adult mice. To our knowledge, this
is the first study showing that nerve injury induces LTP in
pain activated cortical–spinal cord projecting neurons in
the deep layers of the ACC. Potentiation is mediated by
postsynaptic AMPARs, and cAMP-PKA dependent path-
way plays a critical role in this LTP. These findings pro-
vide strong evidence for the first time that potentiated
responses in deep cingulate neurons may subsequentlysponses. A-B, Sample traces showing that NASPM inhibit the layer
ce with sham surgery. C-D, Summarized data showing the effect of
injury or sham surgery. AMPA/KA receptor antagonist CNQX blocked
ed with biocytin (stained with FITC, green, layer V) or Lucifer yellow
Figure 9 GluA1/3 mediated the potentiated AMPAR current on the Fos-positive layer V neurons in mice with nerve injury. A, Digitized
photomicrograph showing one Fos-GFP-positive (Fos+) (1) or one Fos-GFP-negative (Fos-) (2) neuron was whole-cell patched and dual-labeled by
intracellular injection of Alex-594. B, Samples and summarized results showing the AMPAR I-O curve recorded on Fos- neurons in mice with sham
surgery (Sham-Fos-) and on Fos- (Nerve injury-Fos-) and Fos + (Nerve injury-Fos+) neurons in mice with nerve injury, respectively. C, Samples and
averaged results showing that NASPM only inhibited the AMPAR EPSCs on Fos + neurons in mice with nerve injury but not on Fos- neurons in
mice either with nerve injury or sham surgery. D, Plotted figure showing the summarized effect of NASPM on Sham-Fos-, Nerve injury-Fos- and
Nerve injury-Fos + neurons. Bar equals to 20 μm in A. *, p < 0.05; ***, p < 0.001.
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cortical-spinal projecting control. This new mechanism al-
lows synaptic potentiation at single synapse level (i.e.,
postsynaptic sites of deep cingulate pyramidal cells) to in-
fluence sensory pain transmission at distal location, at
dorsal horn of the spinal cord. Synaptic potentiation and
top-down facilitation thus may play important roles in
behavioral hypersensitive responses to sensory stimuli in
chronic pain conditions. Our data provide novel evidence
for the corticospinal pathway as a target for reducing
chronic pain.
Direct corticospinal projections from the ACC
Previous studies from rats and monkeys show that some
of ACC neurons send their projecting fibers to the spinal
cord [33,34]. In the present study, by using different ana-
tomic methods, we have clearly demonstrated that deep
ACC neurons send direct descending projecting fibers to
the spinal cord, especially the dorsal horn for the spinal
cord in adult mice. This top-down corticospinal projection
system is likely important for functional pain modulation,
since our previous study using in vivo preparation showthat spinal nociceptive tail-flick reflex is facilitated by acti-
vation of the ACC [32]. Although our previous studies
found that descending modulation of the tail-flick reflex
depends on brainstem relay, we cannot rule out that top-
down descending facilitation modulation may not require
brainstem relay in certain conditions. Direct descending
projecting pathways could provide fast modulation of
spinal synaptic transmission in an efficient manner. Our
preliminary electrophysiological studies using in vivo
whole-cell patch-clamp recording technique found that
ACC stimulation indeed facilitated excitatory glutamater-
gic transmission in the spinal cord dorsal horn of adult
rats (unpublished data).
Potentiation of excitatory transmission after nerve injury
Recent studies have consistently shown that excitatory
transmission in the layer II/III of the ACC is potentiated
after peripheral nerve injury (see [4]). Both presynaptic
and postsynaptic mechanisms contribute to the potenti-
ation [22]. The present results show that excitatory synap-
tic transmission in the layer V/VI of the ACC is also
potentiated. However, unlike layer II/III, potentiation of
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by postsynaptic mechanisms. However, we cannot rule
out the possibility that some presynaptic mechanism may
also contribute to this potentiation. Similar to layer II/III,
calcium-CaM dependent PKA signaling pathway is critical
for potentiation in layer V/VI neurons. By using dual
paired recordings, we found that inter-cortical connec-
tions between layer II/III cells and layer V cells are also
potentiated.
ACC LTP and postsynaptic GluA1
GluA1 trafficking into the synaptic region is an important
mechanism for postsynaptic form of LTP [43,47,54,55].
Our previous studies using pharmacological and genetic
approaches consistently demonstrate that GluA1 is critical
for ACC LTP [3,56,57]. In the present study, by applying
GluA1/3 antagonist NASPM, we confirm that enhanced
postsynaptic GluA1/3 may contribute to the LTP in ACC-
SC projecting neurons after nerve injury. In a previous
study, we observed through western blot analysis that
nerve injury increases phosphorylated-GluA1 expression
in layer II/III neuronal membrane in the ACC [22]. How-
ever, it is unknown if this PKA phosphorylation is actually
required for chronic pain induced LTP. Through the use
of mice with PKC or PKA phosphorylation site mutations,
we showed that PKA phosphorylated site ser-845 but not
PKC phosphorylated site ser-831 on GluA1 is necessary
for the potentiated AMPAR mediated responses in ACC-
SC projecting neurons. This finding is consistent with pre-
vious work in the ACC that show the requirement of
AC1-cAMP signaling pathway for the induction of ACC
LTP. ACC LTP is blocked in gene knockout mice lacking
AC1 [58], and AC1 inhibitor NB001 prevented the induc-
tion of LTP [24].
Top-down descending facilitation
Spinal nociceptive transmission is under biphasic modula-
tion from supraspinal structures, especially descending
facilitatory modulation [31,59]. Most of previous studies
have mainly focused on descending projections from
brainstem neurons [2,27,60,61], and few studies have re-
ported synaptic plastic changes in these cortical-spinal
top-down projection cells. Using behavioral nociceptive
reflexes, we have previously shown that ACC stimulation
induces the facilitation of the spinal nociceptive tail-flick
reflex [32]. Pharmacological studies revealed that some of
this descending facilitation may rely on brainstem RVM
cells, and the spinal transmitter serotonin is likely a key
mediator for such facilitation [62,63]. In the present study,
we reveal a direct cortical-spinal projecting pathway. Our
preliminary studies show that ACC-spinal cord descend-
ing facilitation does not require the brainstem relay (Chen
et al., unpublished data). Our in vivo electrophysiological
studies show that ACC stimulation can facilitate spinalcord neurons in control condition, while this facilitation is
blocked in chronic pain condition, suggesting that ACC-
SC descending facilitation is tonically activated in neuro-
pathic pain condition (Chen et al., unpublished data).
Considering glutamate is the major transmitter for most
of pyramidal cells in the ACC, it raises the possibility that
glutamate may also act as a transmitter for facilitating pain
transmission in the spinal cord. Different types of glutam-
ate receptors in the spinal cord, such as NMDA receptor,
kainate receptors, metabotropic glutamate receptors as
well as the possible recruitment of postsynaptic AMPARs
may acts as possible candidates mechanisms for the amp-
lified excitation in spinal cord [64-66]. Future studies are
clearly needed to reveal molecular mechanism for this
novel modulation.
Functional implications
The present study provides strong evidence for positive
feedback mechanism at both synaptic and circuit levels in
chronic pain conditions (see Figure 10). At the synaptic
level, this is the first study to show that AMPARs undergo
up-regulation in corticospinal projecting cells from the
ACC. Accordingly, we presented pharmacological and gen-
etic studies confirming the necessity of GluA1 receptors in
ACC potentiation. At circuit level, our results suggest that
potentiated ACC synapses may enhance neuronal spike
responses to incoming sensory inputs from the thalamus.
Consequently, the firing of corticospinal ACC neurons
may trigger spinal facilitation of sensory transmission,
including painful information. In case of nerve injury, this
ACC-SC loop is activated and contributes to the mainten-
ance of behavioral hyperalgesia and allodynia. These find-
ings provide insights for designing new treatment methods
and protocols, as well as exploring possible novel targets
for analgesic drugs. One may reduce chronic pain by inhi-
biting injury triggered potentiation in the cortex, and/or
inhibiting descending facilitation by corticospinal projections
from the ACC. Future studies are clearly needed to identify
the transmitters and mechanisms for such descending facili-
tation in different chronic pain conditions.
Methods
Animals
Adult male C57BL/6, GluA1 serine-831 and serine-845
phosphorylation site mutant (s831A and s845A) mice were
used. Animals were randomly housed under a 12-h light–
dark cycle (9 a.m. to 9 p.m. light), with food and water
freely available, at least one week before carrying out
experiments. All procedures involving animals were under
the guidelines of the Fourth Military Medical University,
Xi’an Jiaotong University, Wuhan Institute of Physics and
Mathematics, the Chinese Academy of Sciences, University
of Toronto, National Institute for Physiological Sciences
and Johns Hopkins University.
Figure 10 A model for the role of cingulate-spinal projection
pathways in pain regulation and their synaptic plasticity after
nerve injury. A, A diagram shows the spinal-cortex-spinal circuit
containing the spinal cord dorsal horn and ACC in the transmission
and modulation of sensory information in chronic pain conditions.
Through the thalamus (Thal), nociceptive information reaches the
neurons in the ACC from the spinal cord dorsal horn. These information
affect neural activities of deeper cingulate neurons by direct thalamic
projecting or intercortical inputs from layer II and III cells. Many of deep
cingulate neurons then send their direct projections to the spinal cord,
and possibly affect spinal pain transmission. B, Detailed cortical circuits
within the ACC. Pyramidal cells in layer II/III form direct synaptic
connections with neurons in layer V/VI within the ACC. Enhanced
synaptic transmission from Layer II/III to V is likely to activate or enhance
descending facilitatory modulation from the ACC to the spinal cord.
C, A synaptic model shows postsynaptic potentiation of excitatory
transmission in layer V cells after peripheral nerve injury. PKA-dependent
AMPARs GluR1/3 subtypes insertion is likely a key cellular mechanism
for this postsynaptic potentiation.
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A model of neuropathic pain was induced by the ligation
of the common peroneal nerve (CPN) as described previ-
ously [21,22]. Briefly, mice were anesthetized by an intra-
peritoneal injection of a mixture saline of ketamine
(0.16 mg/kg) and xylazine (0.01 mg/kg). The CPN was vis-
ible between the anterior and posterior groups of muscles,
running almost transversely. The left CPN was slowly
ligated with chromic gut suture 5–0 until contraction of
the dorsiflexor of the foot was visible as twitching of the
digits. The skin was then sutured and cleaned. Sham
surgery was conducted in the same manner, but the nervewas not ligated. The mice were used for behavior and/or
electrophysiological studies on postsurgical days 7.
Retrograde labeling
The procedure for retrograde tracer injection into the
spinal cord (in the same time with CPN ligation or sham
surgery) or ventral striatum (4 days after CPN ligation
or sham surgery) was according to our previous works
[67,68]. The anesthetic mice were fixed on a stereotaxic
frame. For the spinal cord injection, the skin between
scapulas was incised and paravertebral muscles were cut
off and vertebral plate of the fourth cervical vertebra
was exposed. The vertebral plate was removed and the
intumescentia cervialis was exposed. Then 4% FG (For
FG immunostaining), 0.25% DiI or 10% Alexa-488 Dex-
tran (for whole cell patch recording) distilled in saline
solution was unilaterally pressure-injected (0.1 μl) into
the C4-5 spinal cord with a Hamilton microsyringe
attached with a glass micropipette (tip outer diameters
ranged from 10–20 μm). Those mice were allowed to
survive for one week before continuous immunostaining
or whole cell patch experimental procedures. For ventral
striatum (VS) injection, the skull was exposed, and a
hole was drilled through the skull over the VS (0.38 mm
anterior to bregma, 2.0 mm lateral to the midline and
4.5 mm ventral to the surface of the skull for the VS).
4% FG, 0.25% DiI or 10% Alexa-488 Dextran was unilat-
erally and iontophoretically injected (3-5 μA pulsed,
7 sec on/off ) for 25 min. Those mice were allowed for
three days survive before immunostaining or whole cell
patch experimental procedures.
Anterograde labeling for Pha-L
The procedures for anterograde tracer phaseolus vulgaris
leucoagglutinin (Pha-L; Vector Laboratories, Burlingame,
CA) injection were essentially the same as described by
our group previously [69]. Briefly, The anesthetic mouse
was fixed on a stereotaxic frame and Pha-L was iontopho-
retically injected into unilateral deep layers of the ACC
according to the atlas of the mouse brain (0.98 mm anter-
ior to Bregma, 0.35 mm lateral to the midline and 1.8 mm
deep from cerebral surface). Pha-L was dissolved in a mix-
ture of 0.05 M Tris–HCl buffer and 0.5 M KCl (pH 7.6) to
a final concentration of 2.5% (W/V). The driving current
(positive, 3–5 μA, 7 s on/off) was delivered for 25 min.
After injection, the surgical wounds were carefully su-
tured. Mice were allowed to survive for approximately
2 weeks before perfusion. To examine the Pha-L injection
site and the distribution of anterogradely Pha-L-labeled
fibers and terminals in the spinal cord, coronal sections
containing ACC and sagittal sections containing spinal
cord of cervical enlargement were incubated overnight
with primary antibody goat-anti-Pha-L (1:500, Vector
Laboratories, Burlingame, CA) in the 5 mM sodium
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0.3% Triton X-100, 0.12% lambda-carrageenan, 0.02% so-
dium azide and 1% donkey serum. On the following day,
the sections were incubated in the same dilution solution
containing biotinylated anti-goat IgG (Vector Laborator-
ies, 1:200) for 4 hours. They were then incubated in an
ABC complex (Vector Laboratories, 1:200) for another
90 min. Subsequently, the sections were treated with
50 mM Tris–HCl buffer (pH 7.5) solution that containing
0.02% diaminobenzidine (DAB), 0.015% H2O2 and 0.04%
NiCl2 to intensify DAB-based reaction for 5–15 min. After
the reaction, the sections were mounted onto gelatin-
coated glass slides, dehydrated and coverslipped. To better
reveal the site of ACC, sections containing injection site
were further counterstained with Nissl staining. Sections
were observed under a light microscope (AH-3; Olympus,
Tokyo, Japan).
Anterograde labeling for lentivirus-assistant rabies virus
Virus preparation
To assist the rabies virus–mediated specific labeling of
ACC neurons, a lentivirus plasmid expressing TVA and
mkate2 was constructed by sub-clone the fusion fragment
TVA:2A:mkate2 into the plasmid FUGW (Addgene
14883). This plasmids Lenti-TVA-mKate was packaged in
293-T cells by co-transfection with pMDL g/p RRE and
pMD2.G. At 48 and 72 hours post transfection, the super-
natant was collected and concentrated into 1000-fold
through high speed concentration [70]. The final titer of
the Lenti-TVA-mKate is 3×107 infecting unit per milliliter.
The rabies virus (RV) and the cell lines for rabies propa-
gation and tittering were kindly supplied by Callaway, E.
M and prepared in our laboratory as previously described
[40]. Briefly, RV-G pseudo typed SAD19-ΔG-mcherry was
propagated in B7GG cells, and the supernatant was
harvested with a titer of 105 infecting units/ml. To pro-
duce the EnvA-pseudotyped rabies, a Bhk-Enva cell was
infected with filtered (0.45 μm, Millipore) RV-G-SAD19-
ΔG-mcherry (EnvA-RV-mcherry). At six hours post infec-
tion, the Bhk-Enva cell were digested with 0.25% trypsin
(Hyclone)to eliminate the contamination of RV-G pseudo
typed rabies. During harvest of EnvA-RV-mcherry, the
filtered supernatant was 2000–3000 fold concentrated
through two cycles of high speed concentration as previ-
ous described [71]. The concentrated aliquots were
tittered in 293 t-tva800 cell line. The final titer of EnvA-
RV-mcherry was 2x108 infecting units per milliliter. All
aliquots were stored at −80°C.
Virus anterograde tracing
Virus tracing works were performed in a BSL II animal fa-
cility. To label the ACC neurons, we first micro-injected
200 nl of the VSV-G pseudotyped Lenti-TVA-mKate into
unilateral deep layers of the ACC as same as the Pha-Linjection site. Four days post the infection of lentivirus,
400 nl of the EnvA-RV-mcherry was microinjected into
the ACC. One week after rabies infection, mice were
deeply anesthetized and transcardially perfused. Coronal
brain slices containing the ACC and sagittal spinal slices
containing cervical enlargement were cut with a thickness
of 40 μm and collected serially. For immunohistochemis-
try of the spinal sections, the free-floating sections were
washed in 0.1 M phosphate buffered saline (PBS) solution
for 3 × 5 min, followed by an incubation with 10% normal
goat serum in PBS solution for 1–1.5 hour. Sections were
then incubated overnight in a rabbit polyclonal anti-RFP
(Abcam, ab62341, 1:500) followed with an FITC conju-
gated anti-rabbit serum (1:200) for 4 hour at 4°C.
For fluorescent imaging of the brain sections labeled by
rabies virus or immunostained spinal sections, the sec-
tions were washed with PBS, and wet mounted directly on
Vecta-Shield mounting medium (brain sections were
counterstained with DAPI), sealed with nail polish, imaged
with an upright fluorescence confocal microscopy (Leica
TCS SP8).
Immunohistochemistry for Fos and FG
Seven days after making the nerve injury model, mice
were anaesthetized and perfused with 0.1 mol/L PBS
(pH 7.2–7.4) via the ascending aorta followed by 4% para-
formaldehyde in 0.1 M PB (pH 7.4). The spinal cord and
brain were then removed, and cryoprotected in 0.1 M PB
containing 30% sucrose overnight at 4°C. Transverse sec-
tions (30 μm thickness) of spinal cord and brain samples
were cut on a freezing microtome and collected serially
and seperated as three sets of sections. Sections containing
cervical spinal cord and ventral striatum were collected
for injection sites imaging.
One set of sections containing ACC was used for Fos and
FG immunostaining according to our previous works
[21,72]. In brief, sections were sequentially incubated with
the following solutions: (1) PBS solution of 3% bovine
serum, 0.3% Triton X-100 (PBS-TX) containing mouse
antisera against Fos (1:500, ab11959, Abcam) and rabbit
antisera against FG (1:500, AB153, Millipore) for 2 days at
4°C, (2) an Alexa-594 conjugated anti-mouse (1:200,
Invitrogen) and Alexa-488 conjugated anti-rabbit (1:200,
Invitrogen) antibody in PBS-TX for 24 hrs at 4°C. Sections
were then rinsed in PBS, mounted onto glass slides, air
dried, cover-slipped with a mixture of 50% (v/v) glycerin
and 2.5% (w/v) triethylene diamine in 0.01 M PBS. The
signals were visualized under confocal microscope (FV-
1000; Olympus, Tokyo, Japan) under appropriate filter for
Alexa-488 (excitation 495 nm; emission 519 nm) and
Alexa −594 (excitation 590 nm; emission 617 nm). For
obsevation of the FG/Fos neurons, a careful focusing
through the thickness of all sections determined that the
immunolabeling had penetrated the whole thickness of
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ous light emission were counted. Since the light from
some positive neurons might be too weak to detect, the
numbers of Fos-ir neurons and/or FG labeled neurons in
Tables 1 and 2 should be regarded as representing the
minimum of the real positive neurons in the sections. In
addition, to avoid possible double counting of positive
neurons the sections were carefully moved across the
stage and analyzed from left to right.
One set of sections containing ACC was used for FG
immunostaining and Nissl counterstaining. Sections were
sequentially induced with (1) rabbit antisera against FG
(1:500) for 2 days at 4°C, (2) biotin conjugated goat anti-
rabbit antibody (1:200, Millipore) for 24 hrs at 4°C, (3)
ABC elite kit (1:100) for 2 hrs. Finally, the sections were
reacted with 0.05 M Tris–HCl buffer (pH 7.6) containing
0.04% DAB (Dojin) and 0.003% H2O2 for visualizing FG-
like immunoreactive neurons. Then the sections were
mounted onto gelatin-coated glass slides and processed
for standard Nissl staining.
Another set of sections were used for control staining.
The primary antibodies were omitted or replaced with nor-
mal rabbit/mouse serum and the other procedures were
the same as those for the first 2 sets of sections in all
groups. No staining was observed on brain sections when
the primary antibody was omitted or replaced from the
protocol.
Whole-cell patch-clamp recordings
Coronal brain slices (300 μm) at the level of the ACC were
prepared using standard methods1,9,11. Slices were trans-
ferred to a submerged recovery chamber containing oxy-
genated (95% O2 and 5% CO2) ACSF (124 mM NaCl,
4.4 mM KCl, 2 mM CaCl2, 1 mM MgSO4, 25 mM
NaHCO3, 1 mM NaH2PO4, and 10 mM glucose) at room
temperature for at least 1 hr and then heated up to 32°C
for recording. Evoked EPSCs were recorded from layer V
neurons in randomly selected sides of the ACC, with an
Axon 200B amplifier, and the stimulations were delivered
by a bipolar tungsten stimulating electrode placed in layer
II/III of the ACC. AMPA receptor-mediated EPSCs were
induced by repetitive stimulations at 0.02 Hz, and neurons
were voltage-clamped at −60 mV in the presence of AP5
(50 μM). The recording pipettes (3–5 MΩ) were filled
with a solution containing (in mM) 112 Cs-Gluconate, 5
TEA-Cl, 3.7 NaCl, 0.2 EGTA, 10 HEPES, 2MgATP, 0.3
Na3GTP and 5 QX-314 (adjusted to PH 7.2 with CsOH,
290 mOsmol). 0.1 mM spermine was included into the so-
lution when recording AMPA I-V curve. Picrotoxin
(100 μM) and AP5 (50 μM) was always present to block
γ-aminobutyric acid (A) (GABAA) and NMDA receptor
mediated synaptic currents in all experiments. To test the
miniature EPSC, tetrodotoxin (1 mM) was added into the
ACSF. The initial access resistance was 15–30 MΩ, and itwas monitored throughout the experiment. Data were
discarded if the access resistance changed >15% during
experiment. Data were filtered at 1 kHz, and digitized at
10 kHz.
For recording ACC-spinal cord or ACC-ventral striatum
projecting neurons, the ACC sections were observed under
FV-1000 confocal microscope under proper filters for DiI
(excitation 549 nm; emission 565 nm) or Alexa-488
Dextran Amine. In some cases, Alexa-488 or Alexa-594
was introduced into the recording solution for dual-
labeling of the DiI or Dextran retrograde labeled neurons,
respectively.
Statistical analyses
All experiments were carried out as blind to genotype
and the conditions of the experiments. Data were col-
lected and processed randomly, and no data points were
excluded. No statistical methods were used to predeter-
mine sample sizes, but our sample sizes were similar to
those reported in previous publications. Statistical com-
parisons were made using the unpaired, paired t-test, or
two-way ANOVA (Tukey test was used for post hoc
comparison). The normal distribution and the variation
within each group of data was verified by using Sigma-
plot 11.0 software before applying statistical comparison.
Analyzed numbers (n) for each set of experiments are
indicated in the corresponding figure legends or main text
sections. The examples shown in each figure are represen-
tative and were reproducible at least three times for each
set of experiments. All data were presented as the Mean ±
S.E.M. In all cases, p < 0.05 was considered statistically
significant.
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